scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1017173501 |
P356 | DOI | 10.1038/SJ.BMT.1703324 |
P698 | PubMed publication ID | 11840150 |
P5875 | ResearchGate publication ID | 11521124 |
P2093 | author name string | Cohen B | |
Rodriguez J | |||
Burt RK | |||
Oyama Y | |||
Traynor A | |||
Brush M | |||
P2860 | cites work | Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group | Q28265868 |
Cause of death in patients attending multiple sclerosis clinics | Q28288701 | ||
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group | Q28293763 | ||
Stem cell transplantation in experimental models of autoimmune disease | Q33911440 | ||
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria | Q34064209 | ||
Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation | Q34170816 | ||
Engraftment syndrome following hematopoietic stem cell transplantation | Q34298239 | ||
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group | Q34730962 | ||
Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy | Q40621963 | ||
An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose | Q40624714 | ||
High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. | Q40625080 | ||
Major morbidity related to hyperthermia in multiple sclerosis | Q40837428 | ||
Fever and evoked potentials in multiple sclerosis | Q40848968 | ||
Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring | Q46214595 | ||
Syngeneic bone marrow transplantation eliminates V beta 8.2 T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitis | Q46450850 | ||
Bone marrow transplantation in multiple sclerosis | Q57912389 | ||
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis | Q57912405 | ||
Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study | Q58041660 | ||
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome | Q59649521 | ||
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group | Q70650973 | ||
Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administration | Q73446036 | ||
Autoaggression syndrome resembling acute graft-versus-host disease grade IV after autologous peripheral blood stem cell transplantation for breast cancer | Q77366227 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | multiple sclerosis | Q8277 |
P304 | page(s) | 81-85 | |
P577 | publication date | 2002-01-01 | |
P1433 | published in | Bone Marrow Transplantation | Q4941523 |
P1476 | title | Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis | |
P478 | volume | 29 |
Q44971633 | A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma |
Q35994389 | Autologous haematopoietic-stem-cell transplantation for multiple sclerosis |
Q53538901 | Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis. |
Q39222708 | Engraftment syndrome after allogeneic hematopoietic cell transplantation in adults |
Q43198285 | Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center |
Q38315390 | Engraftment syndrome: double-edged sword of hematopoietic cell transplants |
Q36020897 | Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation |
Q35870515 | Haematopoietic stem cell transplantation for autoimmune disorders: the American perspective |
Q37778984 | Hematopoietic SCT for the treatment of multiple sclerosis |
Q88506851 | Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation |
Q43730168 | Neurologic Complications of Bone Marrow and Stem-cell Transplantation in Patients with Cancer. |
Q104064700 | Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous stem cell transplantation |
Q40517545 | Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection |
Q94671653 | The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium |
Q35106133 | The promise of hematopoietic stem cell transplantation for autoimmune diseases |
Search more.